Patient no. | Sex | Age (y) | Affected level | Duration of symptoms (mo) | JOA score | SUV of 18F-FDG uptake (preoperatively/12 mo after decompressive surgery) | |||||||||||
Deterioration | Preoperative | Post-OP-6 | Post-OP-12 | Improvement | C1 | C2 | C3 | C4 | C5 | C6 | C7 | C1–C7 | |||||
Myelopathy type 1 | |||||||||||||||||
1 | F | 54 | C3–4 | 16 | 2 | 11 | 16 | 16 | 5 | 2.1/1.8 | 1.9/1.8 | 1.8/1.9 | 1.9/1.5 | 1.5/1.6 | 1.5/1.6 | 1.3/1.5 | 1.7/1.7 |
2 | M | 71 | C4–5 | 5 | 4 | 8 | 14 | 15 | 7 | 2.2/2.1 | 2.3/2.2 | 2.3/2.1 | 2.3/1.9 | 2.7/1.8 | 2.2/1.7 | 1.8/1.6 | 2.3/1.9 |
3 | M | 83 | C3–4 | 3 | 3 | 6 | 9 | 12 | 6 | 2.6/2.4 | 2.6/2.1 | 3.0/2.2 | 2.5/1.8 | 2.2/1.7 | 1.9/1.6 | 1.4/1.6 | 2.3/1.9 |
4 | M | 62 | C3–4 | 4 | 3 | 9 | 14 | 15 | 6 | 2.1/1.7 | 1.9/1.4 | 1.7/1.3 | 2.0/1.3 | 1.8/1.2 | 1.4/1.3 | 1.5/1.3 | 1.8/1.4 |
5 | M | 68 | C3–4 | 1 | 2 | 15 | 17 | 17 | 2 | 1.8/1.7 | 1.6/1.4 | 1.9/1.3 | 1.7/1.4 | 1.4/1.3 | 1.2/1.2 | 1.3/1.1 | 1.6/1.4 |
6 | F | 77 | C3–4 | 1 | 8 | 9 | 13 | 16 | 7 | 2.1/2.6 | 2.6/2.4 | 2.6/2.5 | 1.9/2.4 | 1.7/2.6 | 1.5/2.4 | 1.6/2.3 | 2.0/2.5 |
7 | M | 75 | C4–5 | 9 | 3 | 11 | 13 | 15 | 4 | 2.5/3.2 | 2.0/2.7 | 1.9/2.4 | 2.3/2.5 | 1.8/3.4 | 1.9/2.6 | 1.8/2.2 | 2.0/2.7 |
8 | M | 77 | C3–4 | 9 | 2 | 8 | 11 | 12 | 4 | 1.9/NA | 1.6/NA | 1.9/NA | 1.6/NA | 1.5/NA | 1.6/NA | 1.5/NA | 1.7/NA |
9 | M | 68 | C4–5 | 5 | 5 | 10 | 15 | 15 | 5 | 1.6/2.0 | 1.5/1.8 | 1.6/1.7 | 1.9/1.9 | 1.5/1.9 | 1.4/2.1 | 1.4/1.9 | 1.6/1.9 |
10 | M | 72 | C3–4 | 2 | 9 | 8 | 14 | 13 | 5 | 2.4/2.2 | 2.2/1.9 | 2.6/2.0 | 1.9/2.1 | 1.8/1.9 | 1.8/1.7 | 1.5/1.6 | 2.0/1.9 |
Mean | 71 | 5.5 | 4.1 | 9.5 | 13.6 | 14.4 | 4.9 | 2.1/2.2 | 2.0/2.0 | 2.1/1.9 | 2.0/1.9 | 1.8/1.9 | 1.7/1.8 | 1.5/1.7 | 1.9/1.9 | ||
SD | 8 | 4.7 | 2.5 | 2.5 | 2.3 | 1.6 | 1.4 | 0.3/0.5 | 0.4/0.4 | 0.5/0.4 | 0.3/0.4 | 0.4/0.7 | 0.3/0.5 | 0.2/0.4 | 0.3/0.4 | ||
Myelopathy type 2 | |||||||||||||||||
11 | M | 74 | C3–4 | 7 | 0 | 12 | 13 | 13 | 1 | 2.1/1.8 | 2.0/1.6 | 2.0/1.6 | 2.0/1.5 | 1.9/1.5 | 1.7/1.5 | 1.7/1.6 | 1.9/1.6 |
12 | M | 47 | C3–4 | 8 | 1 | 15 | 14 | 14 | −1 | 2.2/2.5 | 2.1/2.1 | 2.2/2.1 | 2.2/1.8 | 2.0/1.8 | 1.7/1.4 | 1.4/1.2 | 2.0/1.8 |
13 | M | 45 | C4–5 | 14 | 1 | 13 | 13 | 13 | 0 | 1.9/2.0 | 1.9/1.6 | 1.7/1.7 | 1.6/1.6 | 1.7/1.5 | 1.5/1.6 | 1.2/1.3 | 1.6/1.6 |
14 | M | 51 | C4–5 | 6 | 1 | 13 | 13 | 13 | 0 | 2.2/1.9 | 1.8/1.7 | 1.7/1.7 | 1.7/1.6 | 1.6/1.4 | 1.4/1.5 | 1.6/1.7 | 1.7/1.6 |
15 | F | 83 | C4–5 | 7 | 1 | 11 | 11 | 12 | 1 | 2.1/NA | 1.7/NA | 1.7/NA | 1.7/NA | 1.5/NA | 1.5/NA | 1.7/NA | 1.7/NA |
16 | M | 60 | C3–4 | 22 | 0 | 11 | 12 | 13 | 2 | 1.6/1.5 | 1.7/1.5 | 1.8/1.4 | 1.7/1.3 | 1.7/1.3 | 1.6/1.3 | 1.4/1.2 | 1.6/1.4 |
17 | M | 53 | C4–5 | 18 | 1 | 9 | 11 | 11 | 2 | 2.1/2.6 | 2.1/2.4 | 2.0/2.5 | 2.2/2.1 | 2.0/1.7 | 1.6/1.4 | 1.2/1.8 | 1.9/2.1 |
18 | M | 76 | C3–4 | 30 | 1 | 8 | 8 | 8 | 0 | 2.4/2.5 | 2.0/1.9 | 2.0/1.8 | 1.9/1.7 | 1.8/1.7 | 1.6/1.6 | 1.4/1.3 | 1.9/1.8 |
19 | M | 46 | C3–4 | 5 | 1 | 15 | 16 | 16 | 1 | 2.1/2.1 | 2.0/2.0 | 1.9/2.0 | 1.9/2.0 | 2.0/1.9 | 1.8/1.7 | 1.7/1.7 | 1.9/1.9 |
20 | M | 56 | C4–5 | 28 | 0 | 9 | 9 | 9 | 0 | 2.0/2.0 | 2.1/1.8 | 2.0/1.6 | 2.0/1.6 | 2.1/1.8 | 1.9/1.7 | 1.6/1.7 | 2.0/1.7 |
Mean | 59 | 14.5 | 0.7 | 11.6 | 12.0 | 12.2 | 0.6 | 2.0/2.1 | 1.9/1.8 | 1.9/1.8 | 1.8/1.7 | 1.8/1.6 | 1.6/1.5 | 1.5/1.5 | 1.8/1.7 | ||
SD | 14 | 9.5 | 0.5 | 2.5 | 2.4 | 2.3 | 1.0 | 0.2/0.4 | 0.2/0.3 | 0.2/0.3 | 0.2/0.2 | 0.2/0.2 | 0.2/0.1 | 0.2/0.2 | 0.2/0.2 |
Clinical deterioration with decrease of JOA score was assessed within last 3 mo before decompressive surgery.
Post-OP-6 = postoperative follow-up after 6 mo; Post-OP-12 = postoperative follow-up after 12 mo; NA = not available.